Responding to and mitigating the impact of the COVID-19 pandemic has catapulted its way to the top of every business operation consideration in each industry and the global market in general. One of the more vulnerable operations for the pharma and biotech industry that we anticipate will continue to require adept and innovative efforts to mitigate impact is the medical product supply chain. Disruptions to medical product supply will not only affect public health, but…
In response to the growing impact of the COVID-19 Coronavirus in Europe, a number of countries have implemented national controls to restrict the export of medicines and medical equipment, such as face masks, gloves, and protective clothing. Over the weekend, the EU Commission reviewed actions taken by Member States and, while it has discouraged Member States from adopting measures which would limit intra-EU trade, it has introduced a temporary export ban on exports of certain…
Baker McKenzie is pleased to invite you to our virtual annual conference Supply Chain Risks & Rewards in Emerging Markets, which will now be offered via a series of four webinars. In addition to providing the latest updates on regional and industry-specific supply chain compliance legal developments and impacts of the novel coronavirus, this webinar series will focus on cutting-edge issues in supply chain risk management— including trade considerations and the impact of the growing environmental, social and…
On March 9, New York Governor Andrew Cuomo announced that in response to the hand sanitizer shortages caused by the spread of the novel coronavirus, New York State will purchase hand sanitizer from a company that employs prison labor. According to Cuomo, the goal is to make 100,000 gallons of hand sanitizer a week. This hand sanitizer will reportedly be provided to state schools and prisons. The announcement has been met with criticism from politicians…
The novel coronavirus outbreak continues to have a substantial impact across the globe. As of the writing of this post, more than 87,000 cases of the coronavirus disease (COVID-19) have been identified in 60 countries and territories around the world, claiming the lives of 2,977 people. Travel restrictions are becoming increasingly tighter at airports, with countries either imposing mandatory health screenings on travellers arriving from certain countries, or denying entry to passengers who have recently…